Fabricio Werdum Received Two Years Of Suspension By USADA For Failed Drug Test

Fabricio Werdum Tested Positive For Prohibited Substance And Gets Two-Year Suspension By USADA

The former UFC heavyweight champion Fabricio Werdum can’t step foot inside the Octagon until 2020. As on Tuesday USADA handed “Vai Cavalo” two years of suspension for failing an out-of-competition drug test earlier this year.

Werdum tested positive for trenbolone and its metabolite epitrenbolone from a sample collected April 25. The failed test forced the ex-champion out of his heavyweight bout against Aleksei Oliynyk that was suppose to headline the upcoming UFC Fight Night 136 fight card in Moscow, Russia on September 15.

From USADA’s website:

USADA announced today that UFC® athlete Fabricio Werdum, of Redondo Beach, Calif., has tested positive for a prohibited substance and received a two-year sanction for his anti-doping policy violation. Werdum, 41, tested positive for trenbolone and its metabolite epitrenbolone following an out-of-competition urine test conducted on April 25, 2018. Trenbolone is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List. Werdum’s two-year period of ineligibility, the standard sanction for a first offense involving a non-Specified Substance, began on May 22, 2018, the date his provisional suspension was imposed.

According to USADA, Werdum’s two-year suspension began on May 22, the date when he was first provisionally suspended.

Former heavyweight champion last competed back in March where he lost a fight to Alexander Volkov via fourth-round knockout at UFC Fight Night 127. The defeat snapped Werdum’s two-fight win streak.

Werdum will be 43 when his suspension will end.

For more MMA News, Rumors and Updates follow the Red Monster on Facebook, Twitter, YouTube and Instagram

Join our list

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

LEAVE A REPLY

Please enter your comment!
Please enter your name here